Jazz Pharmaceuticals (JAZZ) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.82% |
| Dec 31, 2025 | -2.94% |
| Sep 30, 2025 | -7.34% |
| Jun 30, 2025 | -3.68% |
| Mar 31, 2025 | 1.83% |
| Dec 31, 2024 | 5.43% |
| Sep 30, 2024 | 9.39% |
| Jun 30, 2024 | 0.90% |
| Mar 31, 2024 | 2.53% |
| Dec 31, 2023 | 5.15% |
| Sep 30, 2023 | 7.89% |
| Jun 30, 2023 | 0.54% |
| Mar 31, 2023 | -6.13% |
| Dec 31, 2022 | -11.90% |
| Sep 30, 2022 | -16.78% |
| Jun 30, 2022 | -15.23% |
| Mar 31, 2022 | 74.19% |
| Dec 31, 2021 | 88.17% |
| Sep 30, 2021 | 98.32% |
| Jun 30, 2021 | 117.80% |
| Mar 31, 2021 | 29.55% |
| Dec 31, 2020 | 18.00% |
| Sep 30, 2020 | 13.82% |
| Jun 30, 2020 | 10.53% |
| Mar 31, 2020 | -1.23% |
| Dec 31, 2019 | 6.45% |
| Sep 30, 2019 | 0.77% |
| Jun 30, 2019 | 2.61% |
| Mar 31, 2019 | -0.13% |
| Dec 31, 2018 | 1.56% |
| Sep 30, 2018 | 9.74% |
| Jun 30, 2018 | 11.34% |
| Mar 31, 2018 | 9.79% |
| Dec 31, 2017 | 6.74% |
| Sep 30, 2017 | 1.39% |
| Jun 30, 2017 | 39.32% |
| Mar 31, 2017 | 36.23% |
| Dec 31, 2016 | 44.04% |
| Sep 30, 2016 | 42.33% |
| Jun 30, 2016 | 1.62% |
| Mar 31, 2016 | 9.19% |
| Dec 31, 2015 | -0.19% |
| Sep 30, 2015 | 3.49% |
| Jun 30, 2015 | 7.53% |
| Mar 31, 2015 | 1.29% |
| Dec 31, 2014 | 49.18% |
| Sep 30, 2014 | 53.17% |
| Jun 30, 2014 | 50.71% |
| Mar 31, 2014 | 59.05% |
| Dec 31, 2013 | 13.82% |
| Sep 30, 2013 | 26.57% |
| Jun 30, 2013 | 23.32% |
| Mar 31, 2013 | 124.46% |
| Dec 31, 2012 | 675.51% |
| Sep 30, 2012 | 730.89% |
| Jun 30, 2012 | 777.90% |
| Dec 31, 2011 | 86.82% |